There's good news for people in the early stages of Alzheimer's. For the first time in nearly two decades, the FDA has approved a drug to slow progression of the disease. Cleveland Clinic's Doctor Marwan Sabbagh took part in the drug trials.
There's good news for people in the early stages of Alzheimer's. For the first time in nearly two decades, the FDA has approved a drug to slow progression of the disease. Cleveland Clinic's Doctor Marwan Sabbagh took part in the drug trials.